Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
F-actin is essential for cell structure and function, and plays an important role in cell migration
Key research findings include: Average 24.2% body weight reduction in Phase 2 at the highest dose cohort over 48 weeks Significant reductions in waist circumference, triglycerides, and fasting glucose Weekly subcutaneous injection (half-life approximately 6 days) Most common adverse events: nausea, vomiting, diarrhea (typical of GLP-1 class) Requires cold chain storage (28C refrigerated)
Expert perspectives Reacting to the readout, endocrinologist Daniel J
Bad news, okay
Gruber CW, Cemazar M, Heras B, Martin JL, Craik DJ
US$ 21.21
US$ 24.53
US$ 25.47
